Showing posts with label drug discovery. Show all posts
Showing posts with label drug discovery. Show all posts
Tuesday, January 15, 2013
Galapagos creates Fidelta, a third Galapagos service division
Galapagos NV (Euronext: GLPG) announced today that the research site in Zagreb, Croatia, will form the basis of a newly created service division, called Fidelta. Next to BioFocus and Argenta, this is
Labels:
discovery,
drug,
drug discovery,
fidelta,
forward,
forward statements,
galapagos,
galapagos euronext glpg,
glpg,
phase,
programs,
service,
service division,
service division galapagos,
statements
Subscribe to:
Posts (Atom)